Indication:

There are no 'real' bipolar indications for risperidone: Risperdal tablets and liquid, and Risperdal Quicklet are indicated for the treatment of acute and chronic schizophrenic psychoses and other psychotic conditions in which positive symptoms (such as hallucinations, delusions, thought disturbances, hostility, and suspiciousness) and/or negative symptoms (such as blunted affect, emotional and social withdrawal, and poverty of speech) are prominent. Risperdal and Risperdal Quicklet also alleviate affective symptoms (such as depression, feelings of guilt, and anxiety) associated with schizophrenia. Risperdal and Risperdal Quicklet are also effective in maintaining clinical improvement during continuation therapy in patients who have shown an initial treatment response.